期刊文献+

左右半结肠癌患者临床病理特征的比较 被引量:6

Clinicopathological differences between left-sided and right-sided colon cancer
下载PDF
导出
摘要 目的探讨左右半结肠癌患者临床病理特征的差异。方法回顾性分析广西医科大学附属肿瘤医院2004—2019年收治的2163例结直肠癌患者的临床资料,根据肿瘤部位的不同将患者分为左半结肠癌组(n=1634,LCC组)与右半结肠癌组(n=529,RCC组),比较两组一般资料、临床表现、分子生物学特征及病理资料的差异。结果两组性别、年龄比较差异均无统计学意义(均P>0.05),LCC组BMI高于RCC组(P<0.05)。LCC组出现黏液血便、排粪习惯改变、肛门坠胀感的比例高于RCC组,RCC组出现腹痛、腹部肿块的比例高于LCC组(均P<0.05)。LCC组T3~4期、M1期比例低于RCC组,两组TNM分期比较差异有统计学意义(均P<0.05);两组N分期、肿瘤分化程度比较差异均无统计学意义(均P>0.05)。在特征明确的患者中,RCC组NRAS突变比例更低、微卫星不稳定比例更高、有血管浸润的比例更低(均P<0.05);两组KRAS突变比例、神经侵犯、淋巴管浸润比例比较差异均无统计学意义(均P>0.05)。结论LCC患者与RCC患者相比,两者存在BMI、临床表现、肿瘤分期及血管浸润方面的差异,且后者微卫星不稳定比例更高、NRAS突变比例更低。 Objectives To compare the clinicopathological differences between left-sided and right-sided colon cancer.Methods We retrospectively analyzed 2,163 colorectal cancer patients who underwent treatment at Guangxi Medical University Affiliated Tumor Hospital between 2004 and 2019.Patients were divided into left-sided colon cancer group(LCC,n=1,634)and rightsided colon cancer group(RCC,n=529).Demographics,clinical characteristics,molecular characteristics,and pathological characteristics were compared between the two groups.Results The two groups did not differ in sex and age(P>0.05).Body mass index(BMI)was significantly higher in the LCC group than in the RCC group(P<0.05).Patients in the LCC group had significantly higher proportions of existing mucousy and bloodly stool,changes in bowel movement,and rectal distension,while patients in the RCC group had significantly higher proportions of appearing abdominal pain and abdominal mass(P<0.05).Patients in the LCC group had a significantly lower rate of T3~4 staging and M1 staging than in the RCC group(P<0.05).The two groups differed significantly in TNM staging(P<0.05).The N staging and degree of differentiation did not differ between the two groups(P>0.05).Among representative cases,patients in the RCC group had a significantly lower rate of NRAS mutation,a higher rate of microsatellite instability,and a lower rate of vascular infiltration(P<0.05).The two groups were similar in the rate of KRAS mutation,neural infiltration,and lymphatic infiltration(P>0.05).Conclusion Compared with RCC,LCC is different in BMI,clinical presentations,staging,and vascular infiltration.RCC is also more likely to have microsatellite instability but less likely to have NRAS mutation.
作者 柳俊刚 黄晓量 张丽华 邓雨清 廖丽娴 梁丁宇 黄金练 黄李浩赟 莫显伟 唐卫中 Liu Jungang;Huang Xiaoliang;Zhang Lihua;Deng Yuqing;Liao Lixian;Liang Dingyu;Huang Jinlian;Huang Lihaoyun;Mo Xianwei;Tang Weizhong(Colorectal and Anal Ward of Gastrointestinal Surgery,Guangxi Medical University Affiliated Tumor Hospital/High-level Innovation Team of Guangxi Higher Education Institutions/Guangxi Colorectal Cancer Clinical Research Center,Nanning 530021,Guangxi Zhuang Autonomous Region,China)
出处 《结直肠肛门外科》 2021年第3期240-243,共4页 Journal of Colorectal & Anal Surgery
基金 广西结直肠癌临床医学研究中心(桂科AD19245197) 广西高校中青年教师科研基础能力提升项目(2021KY0087) 广西研究生教育创新计划项目(YCSW2021133)。
关键词 左半结肠癌 右半结肠癌 临床病理特征差异 left-sided colon cancer right-sided colon cancer clinicopathological differences
  • 相关文献

参考文献7

二级参考文献85

  • 1Xiang L, Zhan Q, Zhao XH, Wang YD, An SL, Xu YZ, Li AM,Gong W, Bai Y, Zhi FC, Liu SD. Risk factors associated withmissed colorectal flat adenoma: a multicenter retrospective tandemcolonoscopy study. World J Gastroenterol 2014; 20: 10927-10937#[PMID: 25152596 DOI: 10.3748/wjg.v20.i31.10927].
  • 2Benedix F, Kube R, Meyer F, Schmidt U, Gastinger I, Lippert H.Comparison of 17,641 patients with right- and left-sided coloncancer: differences in epidemiology, perioperative course, histology,and survival. Dis Colon Rectum 2010; 53: 57-64 [PMID: 20010352DOI: 10.1007/DCR.0b013e3181c703a4].
  • 3Moritani K, Hasegawa H, Okabayashi K, Ishii Y, Endo T, KitagawaY. Difference in the recurrence rate between right- and left-sidedcolon cancer: a 17-year experience at a single institution. SurgToday 2014; 44: 1685-1691 [PMID: 24126535 DOI: 10.1007/s00595-013-0748-5].
  • 4Wiggers T, Arends JW, Volovics A. Regression analysis ofprognostic factors in colorectal cancer after curative resections. DisColon Rectum 1988; 31: 33-41 [PMID: 3366023].
  • 5Meguid RA, Slidell MB, Wolfgang CL, Chang DC, Ahuja N. Isthere a difference in survival between right- versus left-sided coloncancers- Ann Surg Oncol 2008; 15: 2388-2394 [PMID: 18622647DOI: 10.1245/s10434-008-0015-y].
  • 6Weiss JM, Schumacher J, Allen GO, Neuman H, Lange EO,Loconte NK, Greenberg CC, Smith MA. Adjuvant chemotherapyfor stage II right-sided and left-sided colon cancer: analysis ofSEER-medicare data. Ann Surg Oncol 2014; 21: 1781-1791 [PMID:24643898 DOI: 10.1245/s10434-014-3631-8].
  • 7Elsaleh H, Joseph D, Grieu F, Zeps N, Spry N, IacopettaB. Association of tumour site and sex with survival benefitfrom adjuvant chemotherapy in colorectal cancer. Lancet2000; 355: 1745-1750 [PMID: 10832824 DOI: 10.1016/s0140-6736(00)02261-3].
  • 8Missiaglia E, Jacobs B, D'Ario G, Di Narzo AF, Soneson C,Budinska E, Popovici V, Vecchione L, Gerster S, Yan P, Roth AD,Klingbiel D, Bosman FT, Delorenzi M, Tejpar S. Distal and proximalcolon cancers differ in terms of molecular, pathological, and clinicalfeatures. Ann Oncol 2014; 25: 1995-2001 [PMID: 25057166 DOI:10.1093/annonc/mdu275].
  • 9Sinicrope FA, Mahoney MR, Smyrk TC, Thibodeau SN, WarrenRS, Bertagnolli MM, Nelson GD, Goldberg RM, Sargent DJ, AlbertsSR. Prognostic impact of deficient DNA mismatch repair in patientswith stage III colon cancer from a randomized trial of FOLFOXbasedadjuvant chemotherapy. J Clin Oncol 2013; 31: 3664-3672[PMID: 24019539 DOI: 10.1200/jco.2013.48.9591].
  • 10Yoon HH, Tougeron D, Shi Q, Alberts SR, Mahoney MR, NelsonGD, Nair SG, Thibodeau SN, Goldberg RM, Sargent DJ, SinicropeFA. KRAS codon 12 and 13 mutations in relation to diseasefreesurvival in BRAF-wild-type stage III colon cancers from anadjuvant chemotherapy trial (N0147 alliance). Clin Cancer Res2014; 20: 3033-3043 [PMID: 24687927 DOI: 10.1158/1078-0432.ccr-13-3140].

共引文献87

同被引文献67

引证文献6

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部